Cargando…

A Three lncRNA Set: AC009975.1, POTEH-AS1 and AL390243.1 as Nodal Efficacy Biomarker of Neoadjuvant Therapy for HER-2 Positive Breast Cancer

PURPOSE: The study aimed to explore whether the expression of lncRNAs in primary tumors could predict nodal efficacy after neoadjuvant therapy (NAT) for HER2+ breast cancer. METHODS: Total RNA was extracted from HER2+ breast cancer tissues before NAT (n=103) and from 48 pairs of cancers and para-can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bi, Zhao, Qiu, Peng-Fei, Zhang, Yue, Song, Xing-Guo, Chen, Peng, Xie, Li, Wang, Yong-Sheng, Song, Xian-Rang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685269/ https://www.ncbi.nlm.nih.gov/pubmed/34938660 http://dx.doi.org/10.3389/fonc.2021.779140

Ejemplares similares

LncRNA AC093818.1 accelerates gastric cancer metastasis by epigenetically promoting PDK1 expression
por: Ba, Ming-chen, et al.
Publicado: (2020)

A lncRNA landscape in breast cancer reveals a potential role for AC009283.1 in proliferation and apoptosis in HER2-enriched subtype
por: Cedro-Tanda, Alberto, et al.
Publicado: (2020)

H3K18ac Primes Mesendodermal Differentiation upon Nodal Signaling
por: Luo, Maoguo, et al.
Publicado: (2019)

Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma
por: Gan, Binliang, et al.
Publicado: (2023)

LncRNA AC007255.1, an immune-related prognostic enhancer RNA in esophageal cancer
por: Wang, Qingqing, et al.
Publicado: (2021)

LncRNA AC142119.1 facilitates the progression of neuroblastoma by epigenetically initiating the transcription of MYCN
por: Yang, Rui, et al.
Publicado: (2023)

Negative genic switch of HER-2 in the primary tumor instead of the synchronous metastatic nodal lesions after neoadjuvant chemotherapy in a patient with primary HER2-positive breast cancer
por: Chen, Hao-ran, et al.
Publicado: (2017)

Advanced NODAL course: Session 1 mini-computer systems and NODAL
por: Harrison, C G
Publicado: (1977)

FGFR1 Amplification and Response to Neoadjuvant Anti-HER2 Treatment in Early HER2-Positive Breast Cancer
por: Gaibar, María, et al.
Publicado: (2022)

HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment
por: Novillo, Apolonia, et al.
Publicado: (2023)

Maternal Nodal inversely affects NODAL and STOX1 expression in the fetal placenta
por: Thulluru, Hari Krishna, et al.
Publicado: (2013)

Early assessment of circulating exosomal lncRNA-GC1 for monitoring neoadjuvant chemotherapy response in gastric cancer
por: Guo, Xin, et al.
Publicado: (2023)

PD-1/PD-L1 immune checkpoint inhibitors in neoadjuvant therapy for solid tumors (Review)
por: Tang, Quanying, et al.
Publicado: (2023)

AC138128.1 an Intronic lncRNA originating from ERCC1 Implies a Potential Application in Lung Cancer Treatment
por: Xiao, Mingyang, et al.
Publicado: (2019)

FGFR1 and HER1 or HER2 co-amplification in breast cancer indicate poor prognosis
por: Chen, Shinan, et al.
Publicado: (2018)

LncRNA-AC068228.1 Is a Novel Prognostic Biomarker That Promotes Malignant Phenotypes in Lung Adenocarcinoma
por: Jiang, Xiulin, et al.
Publicado: (2022)

Knockdown of lncRNA HNF1A-AS1 inhibits oncogenic phenotypes in colorectal carcinoma
por: Zhu, Wenyi, et al.
Publicado: (2017)

Knockdown of lncRNA HNF1A-AS1 inhibits oncogenic phenotypes in colorectal carcinoma
por: Zhu, Wenyi, et al.
Publicado: (2019)

PTCH1 and CTNNB1 emerge as pivotal predictors of resistance to neoadjuvant chemotherapy in ER+/HER2- breast cancer
por: Ozcan, Gulnihal
Publicado: (2023)

LncRNA AC136007.2 alleviates cerebral ischemic-reperfusion injury by suppressing autophagy
por: Liu, Na, et al.
Publicado: (2021)

Single-Nucleotide Polymorphism LncRNA AC008392.1/rs7248320 in CARD8 is Associated with Kawasaki Disease Susceptibility in the Han Chinese Population
por: Guo, Kai, et al.
Publicado: (2021)

lncRNA-AC079061.1/VIPR1 axis may suppress the development of hepatocellular carcinoma: a bioinformatics analysis and experimental validation
por: Lin, Xia-Hui, et al.
Publicado: (2022)

MRI for nodal restaging after neoadjuvant therapy in rectal cancer with histopathologic comparison
por: Zhang, Zhiwen, et al.
Publicado: (2023)

Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer
por: Cascone, Tina, et al.
Publicado: (2021)

Regional nodal irradiation (RNI) in breast cancer patients with residual isolated tumor cells or micrometastatic nodal disease after neoadjuvant chemotherapy
por: Kim, Joseph K., et al.
Publicado: (2022)

Familial Occurrence of Atrioventricular Nodal Reentrant Tachycardia in a Mother and Her Son
por: Namgung, June, et al.
Publicado: (2012)

Polymorphism in lncRNA AC008392.1 and its interaction with smoking on the risk of lung cancer in a Chinese population
por: Lv, Xiaoting, et al.
Publicado: (2018)

Identification of pyroptosis-related lncRNA signature and AC005253.1 as a pyroptosis-related oncogene in prostate cancer
por: Yu, JiangFan, et al.
Publicado: (2022)

Ingestion of Bt corn pollen containing Cry1Ab/2Aj or Cry1Ac does not harm Propylea japonica larvae
por: Liu, Yanmin, et al.
Publicado: (2016)

A ROR1-HER3-LncRNA signaling axis modulates the Hippo-YAP pathway to regulate bone metastasis
por: Li, Chunlai, et al.
Publicado: (2017)

The modified shrinkage classification modes could help to guide breast conserving surgery after neoadjuvant therapy in breast cancer
por: Bi, Zhao, et al.
Publicado: (2022)

Serum Exosomal lncRNA AC007099.1 Regulates the Expression of Neuropeptide-Related FAP, as a Potential Biomarker for Hepatocarcinogenesis
por: Li, Luqian, et al.
Publicado: (2022)

The Cadherin Cry1Ac Binding-Region is Necessary for the Cooperative Effect with ABCC2 Transporter Enhancing Insecticidal Activity of Bacillus thuringiensis Cry1Ac Toxin
por: Ma, Yuemin, et al.
Publicado: (2019)

An objective nodal staging system for breast cancer patients undergoing neoadjuvant systemic treatment
por: Yoo, Tae-Kyung, et al.
Publicado: (2017)

Internal mammary lymph nodal response to neoadjuvant chemotherapy on imaging and breast cancer prognosis
por: Adam, Richard, et al.
Publicado: (2022)

Efficacy of TCH/TEC neoadjuvant chemotherapy for the treatment of HER-2-overexpressing breast cancer
por: CHEN, WEICAI, et al.
Publicado: (2015)

Vg1-Nodal heterodimers are the endogenous inducers of mesendoderm
por: Montague, Tessa G, et al.
Publicado: (2017)

Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma
por: Peng, Jian-Heng, et al.
Publicado: (2019)

The role of neoadjuvant her2-targeted therapies in her2-overexpressing breast cancers
por: Lemieux, J., et al.
Publicado: (2009)

New Anti-Nodal Monoclonal Antibodies Targeting the Nodal Pre-Helix Loop Involved in Cripto-1 Binding
por: Focà, Annalia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_l7dii0ur8v8sneptp8cpg3u234